Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity

Journal of Clinical Investigation

Volumn 117, Issue 5, 2007, Pages 1324-1334

  Kuwahara, Koichiro ^a   Teg Pipes, Gordon C ^a   McAnally, John ^a   Richardson, James A ^a   Hill, Joseph A ^a   Bassel Duby, Rhonda ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ATRIAL NATRIURETIC FACTOR; CALCINEURIN; MYOCYTE ENHANCER FACTOR 2; RHO FACTOR; SERUM RESPONSE FACTOR; STRIATED MUSCLE ACTIVATOR OF RHO SIGNALING; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CARDIOMYOPATHY; CONTROLLED STUDY; DETERIORATION; ECHOCARDIOGRAPHY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; HEART FAILURE; HEART FUNCTION; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CARDIOMEGALY; CELL LINE; CELLS, CULTURED; CYTOSKELETON; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MIDDLE AGED; MUTAGENESIS, SITE-DIRECTED; MYOGENIC REGULATORY FACTORS; RATS; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION; VENTRICULAR REMODELING;

EID: 34248168531     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI31240     Document Type: Article

References (43)

1. Chien, K.R., and Olson, E.N. 2002. Converging pathways and principles in heart development and disease: CV@CSH. Cell. 110:153-162.
2. Frey, N., and Olson, E.N. 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65:45-79.
3. Seidman, J.G., and Seidman, C. 2001. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 104:557-567.
4. Granzier, H., Wu, Y., Siegfried, L., and LeWinter, M. 2005. Titin: physiological function and role in cardiomyopathy and failure. Heart Fail. Rev. 10:211-223.
5. Knoll, R., et al. 2002. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell. 111:943-955.
6. Frey, N., et al. 2004. Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat. Med. 10:1336-1343.
7. Purcell, N.H., et al. 2004. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol. Cell. Biol. 24:1081-1095.
8. Philippar, U., et al. 2004. The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. Mol. Cell. 16:867-880.
9. Lange, S., et al. 2005. The kinase domain of titin controls muscle gene expression and protein turnover. Science. 308:1599-1603.
10. Pipes, G.C., Creemers, E.E., and Olson, E.N. 2006. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 20:1545-1556.
11. Miano, J.M. 2003. Serum response factor: toggling between disparate programs of gene expression. J. Mol. Cell. Cardiol. 35:577-593.
12. Sprenkle, A.B., Murray, S.F., and Glembotski, C.C. 1995. Involvement of multiple cis elements in basal- and alpha-adrenergic agonist-inducible atrial natriuretic factor transcription. Roles for serum response elements and an SP-1-like element. Circ. Res. 77:1060-1069.
13. Nelson, T.J., Balza, R., Jr., Xiao, Q., and Misra, R.P. 2005. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. J. Mol. Cell. Cardiol. 39:479-489.
14. Parlakian, A., et al. 2004. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol. Cell. Biol. 24:5281-5289.
15. Miano, J.M., et al. 2004. Restricted inactivation of serum response factor to the cardiovascular system. Proc. Natl. Acad. Sci. U. S. A. 101:17132-17137.
16. Zhang, X., et al. 2001. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am. J. Physiol. Heart Circ. Physiol. 280:H1782-H1792.
17. Chang, J., et al. 2003. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation. 108:407-413.
18. Wang, D., et al. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 105:851-862.
19. Wang, D.Z., et al. 2002. Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc. Natl. Acad. Sci. U. S. A. 99:14855-14860.
20. Cen, B., et al. 2003. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol. Cell. Biol. 23:6597-6608.
21. Wang, Z., Wang, D.Z., Pipes, G.C., and Olson, E.N. 2003. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. U. S. A. 100:7129-7134.
22. Li, S., Wang, D.Z., Wang, Z., Richardson, J.A., and Olson, E.N. 2003. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. U. S. A. 100:9366-9370.
23. Miralles, F., Posern, G., Zaromytidou, A.I., and Treisman, R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 113:329-342.
24. Gossett, L.A., Kelvin, D.J., Sternberg, E.A., and Olson, E.N. 1989. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9:5022-5033.
25. Black, B.L., and Olson, E.N. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
26. McKinsey, T.A., Zhang, C.L., and Olson, E.N. 2002. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27:40-47.
27. Lin, Q., Schwarz, J., Bucana, C., and Olson, E.N. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 276:1404-1407.
28. Naya, F.J., et al. 2002. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 8:1303-1309.
29. Wu, H., et al. 2000. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J. 19:1963-1973.
30. Passier, R., et al. 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105:1395-1406.
31. Xu, J., et al. 2006. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281:9152-9162.
32. Arai, A., Spencer, J.A., and Olson, E.N. 2002. STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J. Biol. Chem. 277:24453-24459.
33. Kuwahara, K., Barrientos, T., Pipes, G.C., Li, S., and Olson, E.N. 2005. Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol. Cell. Biol. 25:3173-3181.
34. Molkentin, J.D., et al. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:215-228.
35. Morin, S., Paradis, P., Aries, A., and Nemer, M. 2001. Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein coupled receptor. Mol. Cell. Biol. 21:1036-1044.
36. Grayson, J., Williams, R.S., Yu, Y.T., and Bassel-Duby, R. 1995. Synergistic interactions between heterologous upstream activation elements and specific TATA sequences in a muscle-specific promoter. Mol. Cell. Biol. 15:1870-1878.
37. Leibham, E., et al. 1994. Binding of TFIID and MEF2 to the TATA element activates transcription of the Xenopus MyoDa promoter. Mol. Cell. Biol. 14:686-699.
38. Xing, W., et al. 2006. Myocardin induces cardiomyocyte hypertrophy. Circ. Res. 98:1089-1097.
39. Parlakian, A., et al. 2005. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Circulation. 112:2930-2939.
40. Kuwahara, K., et al. 2001. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol. Cell. Biol. 21:2085-2097.
41. Nakagawa, O., et al. 2005. Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2. Genes Dev. 19:2066-2077.
42. Cheng, T.C., Hanley, T.A., Mudd, J., Merlie, J.P., and Olson, E.N. 1992. Mapping of myogenin transcription during embryogenesis using transgenes linked to the myogenin control region. J. Cell Biol. 119:1649-1656.
43. Hill, J.A., et al. 2000. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation. 101:2863-2869.